DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Jun 20, 2017 · 9y ago · Accession 0001654954-17-005721
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Jun 20, 2017
- Report date
- Aug 10, 2017
- Document
- cxdo_def14a.htm
- Size
- 198 KB